Who Owns Lakewood-Amedex Biotherapeutics Stock?
NASDAQ: LABTHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 6.02%
- Held by insiders
- 39.47%
- Institutional holders
- 7
- Institutions 6.0%
- Insiders 39.5%
- Public and other 54.5%
Who owns Lakewood-Amedex Biotherapeutics stock?
Institutional investors own about 6.0% of Lakewood-Amedex Biotherapeutics's shares, spread across 7 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 39.47% of LABT.
The largest institutional holders are Marex Group Ltd. (2.03%), HRT Financial LP (1.89%) and UBS Group AG (0.17%). Together, the top 6 institutions control 4.1% of shares outstanding. In their latest filings, 6 of the top 6 institutions increased their LABT positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LABT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Marex Group Ltd. | 48.17K | 2.03% | +100.0% |
| HRT Financial LP | 44.78K | 1.89% | +100.0% |
| UBS Group AG | 4.10K | 0.17% | +100.0% |
| Tower Research Capital LLC (TRC) | 624 | 0.03% | +100.0% |
| Osaic Holdings Inc. | 138 | 0.01% | +100.0% |
| Blue Trust, Inc. | 11 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LABT
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 1.49K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Lakewood-Amedex Biotherapeutics?
Marex Group Ltd. is the largest institutional shareholder of LABT, owning 2.03% of shares outstanding (48.17K shares) as of its latest 13F filing.
What percentage of Lakewood-Amedex Biotherapeutics is owned by institutions?
Institutions own about 6.0% of LABT shares and 9.9% of the public float.
How much of Lakewood-Amedex Biotherapeutics do insiders own?
Insiders, such as officers and directors, own about 39.47% of LABT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.